Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral paclitaxel vs paclitaxel injection in HER2-negative recurrent or metastatic breast cancer
CTR20190448Phase 3Completed
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in breast cancer, sponsored by Daehwa Pharmaceutical Co., Ltd.. Started Mar 2019; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20190448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190448.